Actuate Therapeutics (ACTU) Interest & Investment Income (2023 - 2025)
Actuate Therapeutics (ACTU) posted quarterly Interest & Investment Income of $139582.0 for Q4 2025, up 18.17% year-over-year from $118115.0 in Q4 2024, and up 99.49% quarter-over-quarter from $69971.0 in Q3 2025.
Actuate Therapeutics (ACTU) Interest & Investment Income (2023 - 2025) Analysis & Trends
Actuate Therapeutics (ACTU) has reported Interest & Investment Income for 3 consecutive years, with $139582.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Interest & Investment Income rose 18.17% year-over-year to $139582.0; the TTM figure through Dec 2025 stood at $287710.0 (up 29.43% YoY), while the FY2025 annual figure was $287710.0, up 29.43% from the prior year.
- Interest & Investment Income advanced to $139582.0 in Q4 2025 per ACTU's latest filing, from $69971.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $139582.0 in Q4 2025 and bottomed at $8645.0 in Q2 2024.
- Historically, Interest & Investment Income has averaged $69563.5 across 3 years, with a median of $64829.5 in 2023.
- Annual changes were most pronounced in 2024 — Interest & Investment Income slumped 35.89% — and 2025, when it surged 262.66%.
- Actuate Therapeutics' Interest & Investment Income stood at $59688.0 in 2023, then soared by 97.89% to $118115.0 in 2024, then gained by 18.17% to $139582.0 in 2025.
- Business Quant data shows ACTU's Interest & Investment Income at $139582.0 in Q4 2025, $69971.0 in Q3 2025, and $24534.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | Actuate Therapeutics | 30.08 Mn | 30.08 Mn | - | 45,016.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 139,582.00 |
| Sep 30, 2025 | 69,971.00 |
| Jun 30, 2025 | 24,534.00 |
| Mar 31, 2025 | 53,623.00 |
| Dec 31, 2024 | 118,115.00 |
| Sep 30, 2024 | 80,747.00 |
| Jun 30, 2024 | 8,645.00 |
| Mar 31, 2024 | 14,786.00 |
| Dec 31, 2023 | 59,688.00 |
| Sep 30, 2023 | 125,944.00 |